Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QingSong HealthHKSE:02661 -1.08%18 EV-to-FCF is -0.92 as of Aug. 26, 2026. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 413 Healthcare Providers & Services companies, QingSong Health ranks better than 98.79% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, QingSong Health's Enterprise Value is HK$-82 Mil.
QingSong Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$89 Mil. Therefore, QingSong Health's EV-to-FCF for today is -0.92.
The historical rank and industry rank for QingSong Health's EV-to-FCF or its related term are showing as below:
HKSE:02661'
s EV-to-FCF Range Over the Past 10 Years
Min: -7.02 Med: 35.62 Max: 151.24
Current: -0.92
During the past 4 years, the highest EV-to-FCF of QingSong Health was 151.24. The lowest was -7.02. And the median was 35.62.
HKSE:02661's EV-to-FCF is ranked better than 98.79% of 413
companies
in the Healthcare Providers & Services industry
Industry Median: 18.61
vs HKSE:02661: -0.92
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
QingSong Health (HKSE:02661) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
QingSong Health's PE Ratio (TTM) for today is calculated as:
QingSong Health's share price for today is HK$5.045.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. QingSong Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-2.037.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
QingSong Health EV-to-FCF Related Terms
QingSong Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for QingSong Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02661 vs VEEV, BTSG, HQY: EV-to-FCF Comparison
For the Health Information Services subindustry, QingSong Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QingSong Health EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, QingSong Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where QingSong Health's EV-to-FCF falls into.
QingSong Health's current Enterprise Value is HK$-82 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. QingSong Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$89 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QingSong Health (HKSE:02661) has a EV-to-FCF of -0.92 as of Aug. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on QingSong Health and its competitors. According to the industry distribution chart, QingSong Health ranks #5 out of 413 companies in the Healthcare Providers & Services industry, placing it in the top 1.2%.
Is QingSong Health's EV-to-FCF too high?
QingSong Health's current EV-to-FCF is -0.92. Based on the distribution chart, QingSong Health ranks #5 out of 413 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, QingSong Health ranks #5 out of 413 companies for EV-to-FCF. This places QingSong Health in the top 1% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.61, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on QingSong Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QingSong Health's current EV-to-FCF is -0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current EV-to-FCF of -0.92. The current EV-to-FCF is -0.92. QingSong Health's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current EV-to-FCF is -0.92 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score
Get the complete analysis for HKSE:02661
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02661 has been successfully added to your 
